Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening services. The company was founded in 2001 and is based in New Taipei City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.5672706310195846 | N/A |
Market Cap | $41.10M | N/A |
Shares Outstanding | 72.45M | N/A |
Employees | 0 | N/A |